Key Takeaways
- HubSpot shares plummeted over 24% during Friday’s premarket session following quarterly results
- Q1 revenue of $881M surpassed expectations, yet annual guidance fell short of Wall Street’s hopes
- Cantor Fitzgerald and William Blair issued downgrades on the software stock
- Extended sales cycles and disruptions from sales team retraining impacted the company’s outlook
- Morgan Stanley reduced its target price from $405 down to $350 while keeping an Overweight stance
HubSpot (HUBS) experienced a severe selloff exceeding 24% in premarket hours on Friday, with shares opening at $243.74, as the marketing software company’s first-quarter performance sparked doubts about whether it can achieve the expansion rates Wall Street anticipated.
The top-line figures looked impressive on their own. The company posted $881 million in revenue, representing 23% growth compared to the prior year and exceeding the analyst consensus of $863 million. Earnings per share reached $2.72, topping the $2.47 estimate by a comfortable $0.25 margin. The company’s operating margin delivered 17.8%, beating projections by 100 basis points.
The problem wasn’t the quarter—it was what comes next.
HubSpot’s forward-looking revenue projections didn’t incorporate the first-quarter outperformance as robustly as analysts had hoped. According to Cantor Fitzgerald, the company passed along approximately two-thirds of its Q1 beat into its fiscal 2026 guidance. This conservative approach essentially placed the high-teens to approximately 20% constant-currency expansion many on Wall Street were anticipating beyond reach.
Cantor downgraded shares to Neutral from Overweight while dropping its price target dramatically from $325 to $200. William Blair similarly shifted to Market Perform from its previous Outperform rating.
Sales Force Challenges Compound Concerns
Compounding matters was an operational hiccup at the beginning of the second quarter. HubSpot dedicated roughly one week in April to retraining its entire sales organization following modifications connected to its Spring Spotlight product rollout. This interruption hampered early momentum in the current quarter.
Executives also highlighted lengthening sales cycles as a headwind. Cantor’s research team characterized many of these factors as “self-inflicted choices” implemented with long-term strategic advantages in mind, though they’re expected to suppress growth rates over the coming quarters.
Morgan Stanley maintained its Overweight recommendation but lowered its price objective from $405 to $350. Additional firms including Wells Fargo, Needham, Stifel, and Citigroup similarly reduced their targets. Needham made the most aggressive adjustment, slashing from $700 down to $300 while preserving its Buy recommendation.
Current Analyst Sentiment
Despite the selloff, Wall Street’s overall perspective remains cautiously optimistic. Among the 29 analysts followed by MarketBeat, 23 maintain Buy ratings, four assign Hold ratings, and two recommend Sell. The mean price target stands at $365.96—significantly above current trading levels.
HubSpot’s 52-week peak reached $682.57. The stock touched a low of $187.45 during that same timeframe.
For the second quarter of fiscal 2026, management projects earnings per share between $3.00 and $3.02. Full-year EPS guidance ranges from $13.04 to $13.12.
Insider transactions have drawn attention recently. Board member Brian Halligan divested 8,500 shares in March at a price of $262.75 per share. Insider Erika Ashley Fisher sold 915 shares on May 4th at $236.66, a sale linked to tax requirements from equity compensation vesting.
Regarding institutional movements, T. Rowe Price expanded its holdings by 36.5% during the fourth quarter, while AQR Capital Management more than doubled its stake with a 117.6% increase. Institutional ownership accounts for 90.39% of outstanding shares.
HUBS currently trades at a market capitalization of $12.55 billion with a price-to-earnings ratio of 280.16.
